Topics

GlaxoSmithKline's M72/AS01E vaccine shows sustained protection against active pulmonary #tuberculosis http://www.firstwordpharma.com/node/1677079  $GSK

07:00 EDT 29 Oct 2019 | FirstWord Pharma

GlaxoSmithKline's M72/AS01E vaccine shows sustained protection against active pulmonary http://www.firstwordpharma.com/node/1677079 

Original Article: GlaxoSmithKline's M72/AS01E vaccine shows sustained protection against active pulmonary #tuberculosis http://www.firstwordpharma.com/node/1677079  $GSK

NEXT ARTICLE

More From BioPortfolio on "GlaxoSmithKline's M72/AS01E vaccine shows sustained protection against active pulmonary #tuberculosis http://www.firstwordpharma.com/node/1677079  $GSK"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...